MDS Capital
Venture capital · New York, New York, United States
Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
5Deep-tech portfolio1 active
4Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Zymeworks
3Co-investorsShare a portfolio company
Portfolio · 5 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Mojix | Medtech | Active | Jun 2, 2015 | $2.7M |
| Zymeworks | Biotech | Public | Jan 3, 2024 | $50.0M |
| Argos Therapeutics | Biotech | Acquired | Aug 27, 2013 | $55.4M |
| Angiotech Pharmaceuticals | Medtech | Acquired | — | — |
| Neuromed Pharmaceuticals | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#81
Portfolio exits#49
Raises, 12 months#88
Co-investors#221
Co-investors
- Hatteras FundsVenture capital1 shared
- Pappas VenturesVenture capital1 shared
- Versant VenturesVenture capital1 shared
Sectors
- Biotech3
- Medtech2
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.